There has been much discussion lately about the promise of a newer approach known as enzymatic DNA synthesis, which has been billed as the solution to problems associated with traditional chemical ...

Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based ...

A study published in The International Journal of Oral & Maxillofacial Implants suggests that enzymatic cleaners fail to ...

Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset——Joint poster presentation with Bachem to ...

It might be possible for people in the future to consume BHB-Phe to drive weight loss without restricting carbohydrates in ...

20 partners have joined forces, under the lead of the University College Dublin and BiOrbic Bioeconomy SFI Research Centre.

Summary: Scientists have identified BHB-Phe, a natural compound produced by the body, that regulates appetite and body weight ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...